| http://dbpedia.org/ontology/abstract
|
JWH-371 ([5-(4-butylphenyl)-1-pentylpyrrol … JWH-371 ([5-(4-butylphenyl)-1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone) is a synthetic cannabinoid from the naphthoylpyrrole family which acts as an agonist of the CB1 (Ki = 42 ± 1nM) and CB2 (Ki = 64 ± 2nM) receptors, binding ~1.5 times stronger to the CB1 receptor than the CB2 receptor. JWH-371 was first synthesized in 2006 by John W. Huffman and colleagues to examine the nature of ligand binding to the CB1 receptor.ure of ligand binding to the CB1 receptor.
|
| http://dbpedia.org/ontology/pubchem
|
44418349
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/JWH-371.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
68529216
|
| http://dbpedia.org/ontology/wikiPageLength
|
3958
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1102142847
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Cannabinoid_receptor_1 +
, http://dbpedia.org/resource/John_W._Huffman +
, http://dbpedia.org/resource/Misuse_of_Drugs_Act_1971 +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Synthetic_cannabinoid +
, http://dbpedia.org/resource/Cannabinoid_receptor_2 +
, http://dbpedia.org/resource/List_of_JWH_cannabinoids +
, http://dbpedia.org/resource/Category:JWH_cannabinoids +
, http://dbpedia.org/resource/Controlled_Drugs_and_Substances_Act +
, http://dbpedia.org/resource/Category:Naphthoylpyrroles +
, http://dbpedia.org/resource/Category:CB1_receptor_agonists +
, http://dbpedia.org/resource/Category:CB2_receptor_agonists +
|
| http://dbpedia.org/property/c
|
30
|
| http://dbpedia.org/property/chemspiderid
|
23277927
|
| http://dbpedia.org/property/h
|
33
|
| http://dbpedia.org/property/iupacName
|
[5--1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone
|
| http://dbpedia.org/property/legalCa
|
Schedule II
|
| http://dbpedia.org/property/legalUk
|
Class B
|
| http://dbpedia.org/property/n
|
1
|
| http://dbpedia.org/property/o
|
1
|
| http://dbpedia.org/property/pubchem
|
44418349
|
| http://dbpedia.org/property/smiles
|
CCCCCN1C=CCC3=CC=CC4=CC=CC=C43
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
PKNGYYSGLHBRGC-UHFFFAOYSA-N
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Ebicite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Cn +
, http://dbpedia.org/resource/Template:Cannabinoid-stub +
, http://dbpedia.org/resource/Template:Cannabinoids +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:CB1_receptor_agonists +
, http://dbpedia.org/resource/Category:CB2_receptor_agonists +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:JWH_cannabinoids +
, http://dbpedia.org/resource/Category:Naphthoylpyrroles +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/JWH-371?oldid=1102142847&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/JWH-371.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/JWH-371 +
|
| owl:sameAs |
http://dbpedia.org/resource/JWH-371 +
, http://www.wikidata.org/entity/Q108189108 +
, https://global.dbpedia.org/id/FntX8 +
|
| rdf:type |
http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
JWH-371 ([5-(4-butylphenyl)-1-pentylpyrrol … JWH-371 ([5-(4-butylphenyl)-1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone) is a synthetic cannabinoid from the naphthoylpyrrole family which acts as an agonist of the CB1 (Ki = 42 ± 1nM) and CB2 (Ki = 64 ± 2nM) receptors, binding ~1.5 times stronger to the CB1 receptor than the CB2 receptor. JWH-371 was first synthesized in 2006 by John W. Huffman and colleagues to examine the nature of ligand binding to the CB1 receptor.ure of ligand binding to the CB1 receptor.
|
| rdfs:label |
JWH-371
|
